ISSN: 2155-983X
+44 1300 500008
Usama Ahmad and Md Faiyazuddin
Nanobots
are considered to be the next generation of nanomachines. Several new therapies have already received FDA approval for use treating cancer that rely on nanoparticle delivery vehicles, but till date; none have used computer programs that control smart nanobots capable of performing targeted drug delivery. Scientists hope that by creating smart nanobots, they will be able to program them to deliver highly toxic medicines directly to cancer tumors without compromising surrounding tissue. We present here nanobots as the future of
nanomedicine
and biotherapeutics.